Company Overview

Arjo AB (publ) is a Sweden-based medical technology company specializing in products and solutions designed to enhance mobility, dignity, and care efficiency for patients with reduced mobility. The company operates within the global healthcare equipment and services industry, primarily serving hospitals, long-term care facilities, and other institutional healthcare providers. Its core offerings focus on safe patient handling, medical beds, hygiene and disinfection systems, and wound care, which together represent the company’s principal revenue drivers.

Founded in 1957 in Malmö, Sweden, Arjo has evolved from a regional patient-handling equipment provider into a global medtech company. A significant milestone in its development was its separation from Getinge AB in 2017, after which it became an independent publicly listed company on the Nasdaq Stockholm. Arjo’s strategic positioning emphasizes clinical outcomes, caregiver safety, and workflow efficiency, supported by a broad installed base and recurring revenue from service, rental, and consumables.

Business Operations

Arjo generates revenue through the design, manufacture, sale, rental, and servicing of medical devices and related solutions. Its core business is organized around product-focused operations including Medical Beds, Patient Handling, Hygiene & Disinfection, and Wound Care, with services and consumables providing a recurring revenue component. The company maintains control over proprietary technologies related to patient mobility systems, pressure injury prevention, and infection control.

Operations are conducted across both domestic and international markets, with manufacturing, sales, and service activities spanning multiple regions. Arjo sells directly to healthcare providers and also operates service and rental models, particularly in mature markets. The company operates through numerous wholly owned subsidiaries, including Arjo Inc. and Arjo UK Ltd, which support localized sales, service, and regulatory compliance. No material joint ventures have been consistently identified in public filings, and partnership activity is primarily commercial or distribution-based.

Strategic Position & Investments

Arjo’s strategic direction centers on organic growth in core product categories, operational efficiency, and expansion of service-based revenues. Growth initiatives include innovation in pressure injury prevention, digital-enabled hospital beds, and solutions addressing infection control and caregiver ergonomics. The company has also emphasized margin improvement and portfolio optimization following its post-spin-off restructuring.

Investment activity has historically focused on targeted acquisitions that strengthen existing product lines, particularly within Wound Care and patient handling technologies. Notable past acquisitions include Getinge’s patient handling portfolio, which formed the foundation of Arjo’s current business; however, more recent large-scale acquisitions are limited, and publicly available information on newer transactions is mixed. Data inconclusive based on available public sources regarding material acquisitions after 2022. Arjo continues to invest in incremental innovation rather than large transformative deals.

Geographic Footprint

Arjo is headquartered in Malmö, Sweden, and maintains a broad global presence across Europe, North America, Asia-Pacific, and Latin America. The company derives a significant portion of its revenue from Western Europe and North America, where demand for advanced patient handling and hospital infrastructure is well established.

International operations are supported by regional sales organizations, manufacturing sites, and service hubs, allowing Arjo to adapt products to local clinical practices and regulatory requirements. Emerging markets represent a smaller but growing share of revenue, with targeted expansion in parts of Asia-Pacific and Eastern Europe. The company’s global footprint supports both direct sales and long-term service contracts with multinational healthcare providers.

Leadership & Governance

Arjo is led by an executive management team with experience in medical technology, industrial operations, and global healthcare markets. The leadership emphasizes patient safety, evidence-based solutions, and sustainable value creation for healthcare systems and shareholders. Governance follows Swedish corporate standards and public market requirements, with oversight by an independent board of directors.

Key executives include:

• Joacim Lindoff – President & Chief Executive Officer
• Kristian Rantner – Chief Financial Officer (role and appointment date data inconclusive based on available public sources)
• Jenny Larsson – Executive Vice President, Human Resources
• Anders Dahl – Executive Vice President, Global Sales & Marketing (title and scope based on public disclosures; exact responsibilities may vary)

Leadership philosophy centers on operational excellence, compliance with healthcare regulations, and long-term partnerships with care providers, as consistently articulated in public statements and annual reporting.